Colgate-Palmolive Company reported second quarter 2026 results on July 31, 2026. Net sales increased 4.9% to $5,361 million, while organic sales grew 2.4%. GAAP diluted earnings per share decreased 5% to $0.86, compared to $0.91 in the prior year period; however, Base Business EPS rose 8% to $0.99. Gross profit margin expanded by 140 basis points to 61.5%. The company maintained its full-year net sales guidance of 2% to 6% growth and updated its gross profit margin and Base Business EPS expectations to roughly flat and mid-single-digit growth, respectively. Colgate-Palmolive Company operates in the consumer packaged goods industry, manufacturing and selling oral care, personal care, home care, and pet nutrition products globally.

Colgate-Palmolive Company has expanded its Strategic Growth and Productivity Program, increasing estimated cumulative pre-tax charges to between $350 million and $550 million. This represents a significant increase from the company's previous estimate of $200 million to $300 million in total charges.

Colgate-Palmolive Company announced that Chief Legal Officer and Secretary Jennifer M. Daniels will retire in 2026, with Betsy Fishbone appointed to succeed her effective June 1, 2026. To facilitate an orderly transition, Ms. Daniels will transition to the role of Vice Chair of the Company on the same date.

Colgate-Palmolive Company has elected Christopher S. Boerner, the CEO and Board Chair of Bristol-Myers Squibb, to its Board of Directors effective March 15, 2026. Additionally, Steven A. Cahillane announced he will not stand for reelection to the Board at the company's Annual Meeting of Stockholders on May 8, 2026.